Allergy Therapeutics PLC (STU:HHU)
€ 0.054 0 (0%) Market Cap: 298.78 Mil Enterprise Value: 320.81 Mil PE Ratio: 0 PB Ratio: 52.40 GF Score: 0/100

Allergy Therapeutics plc - Special Call Transcript

Sep 23, 2020 / 08:30AM GMT
Operator

Good morning, ladies and gentlemen, and welcome to Allergy Therapeutics' preliminary results conference call and webinar. (Operator Instructions) I will now hand over to Manuel Llobet, CEO of Allergy Therapeutics. Please go ahead.

Manuel Llobet
Allergy Therapeutics plc - CEO & Executive Director

Thank you very much, and very welcome, all of you, and thank you for coming and attending this presentation on our preliminary results for the year ending 30th of June 2020. Clearly, we would have preferred to have this meeting face-to-face as we usually do. We'll miss the individual chitchats that we have after the presentation. But that's the way it is.

So I'm joining today with our Chief Financial Officer, Nick Wykeman; and our Head of Communications Strategy, Alan Bullimore, who will also develop parts of this presentation. So moving to Slide #2, I'll just bring your attention on the standard disclaimer slide, which is included in this presentation for completeness.

And now we can go to Slide #3, where we have an overview of the presentation.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot